...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Expands Phase 2b Clinical Trial for COVID-19

Possibly because of this ?

 “In consultation with Health Canada, we’ve updated our study protocol to account for the new variants, which could positively enhance the swiftness of patient enrollment. Our goal is to continue advancing the clinical development of apabetalone, thus providing critical and affordable help in the fight against the ongoing pandemic.”

Share
New Message
Please login to post a reply